§ Mr. PikeTo ask the Secretary of State for Health what representatives she has received on piggyback licensing on the back of generic drugs; what is her charging policy in such instances; and if she will make a statement.
§ Mr. SackvilleApplications made under article 4.8.a.i, of directive 65/65/EEC—sometimes known as piggyback applications—are permitted for generic drugs. The application fee, payable on receipt of the application, is presently £2,090. We are not aware of any recent representations about these applications.